Thromo targets corporation Pages on BioPortfolio:

BioPortfolio - ThromboTargets Corporation
ThromboTargets Corporation - Entry on Bioportfolio's Biocorporate Database. ... Spain) projected for Target Identification, Lead Validation, ...
http://www.bioportfolio.com/biocorporate/31064-Thrombo_Targe...

Inhibitors of Gas6 as improved anti-thrombosis candidates
Welfide Corp. Bayer Pharmacia CSL Mediolanum Abbott Mediolanum Aventis ... Comparison of Gas6 inhibitors with other targets: Despite the usefulness of ...
http://www.bioportfolio.com/LeadDiscovery/0246.htm...

BioPortfolio - Molecular Oncology
... human genetic disease pdf | molecular oncology news | From single- to multi- target drugs in cancer therapy when aspecificity becomes an advantage | Curr ...
http://www.bioportfolio.com/biocorporate/7197-Molecular+Onco...

TGX-mAbFVIII-1, a type II monoclonal antibody to Factor VIII for ...
Comparison of TGX-mAbFVIII-1 with other targets: LWMHs have offered a ... Factor VIII has traditionally been avoided as an anti-coagulant target due to the ...
http://www.bioportfolio.com/LeadDiscovery/thr004.htm...

BioPortfolio - the biotechnology, pharmaceutical, life science and ...
BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease. Search BioPortfolio: BioPortfolio ...
http://www.bioportfolio.com/...

Results from other life science and pharmaceutical sites:

AACR-NCI-EORTC - 17th Symposium: Molecular Targets and Cancer ...
The Thomson Corporation ISSN 1369-7056. Introduction. This year's AACR-NCI-EORTC conference on Molecular. Targets and Cancer Therapeutics took place at the ...
http://www.biomedcentral.com/content/pdf/cd-642363.pdf...

Summary Report 2007
In 2007, our corporation-wide net sales rose to EUR 10952 million. .... measure our performance and provide a basis for our annual targets. ...
http://www.boehringer-ingelheim.com/Corporate/annual/pdf/Sum...

Immunotherapy of malignant diseases: cancer therapy beyond ...
approved for routine clinical use,together with their target anti- .... well- defined tumour antigens that are target structures for ...
http://www.roche.com/pages/downloads/company/pdf/rtpenzberg0...

A Graphic Nomogram for Warfarin Dosage Adjustment
At the next clinic visit, which ranged from 10-14 days later, the INR was determined to assess whether the target value was achieved. ...
http://www.medscape.com/viewarticle/417964_2...

Re-Admission Rates within 28 Days of Total Hip Replacement
... have been developing the use of clinical indicators as a tool for comparing performance, target setting, and to promote improvements in quality of care. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=19...

The Heart and Drug Therapy : Article : Nature
It may then be possible to target the development of the arrhythmia substrate ( i.e. upstream therapy), rather than modulating its result. ...
http://www.nature.com/nature/journal/v415/n6868/full/415244a...

Publication of GlaxoSmithKline Merger Documentation
SmithKline Beecham is an industry leader in discovery genomics and bioinformatics, with access to a large range of new drug targets originating
from the ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...

Actelion Annual Report 2004 - CEO's Letter - Clinical Development
BUILD-1 enrolled 158 patients (target: 132) and BUILD-2, 162 patients ... The enrollment target for this clinical trial with Tracleer® is 170 patients. ...
http://www.actelion.com/annualreports/annualreport04/home/pr...

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright 1997-2008 - BioPortfolio Limited.